This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about the link between company’s fundamentals and stock market performance.
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet ...
Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. The drug had total sales of ...
Hosted on MSN
Caplin Point buys $473 million portfolio of US-approved injectable and ophthalmic ANDAs
Caplin Point Laboratories Limited ( (IN:CAPLIPOINT)) has shared an update. Caplin Point Laboratories, through its subsidiaries Caplin Steriles and Caplin One Labs, has acquired 10 approved Abbreviated ...
Following the sharp sell-off, the market is expected to consolidate and trade in a range-bound manner. Below are some ...
Track Caplin Point Laboratories share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...
Caplin Steriles Ltd, a subsidiary of Chennai-based Caplin Point Laboratories Ltd, said its board has approved setting up of a wholly-owned subsidiary in the US. In a regulatory filing, the company ...
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is utilised to lower increased intraocular pressure in individuals with glaucoma or ocular hypertension Caplin Steriles, part of Caplin ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We think all investors should try to buy and hold high quality multi-year ...
https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/caplin-point-laboratories-getting-the-growth-formula-right/article33481737.ece Copy ...
The investment is stated to accelerate Caplin Point's subsidiary's efforts to cater to the growing demand for injectable pharmaceutical products in the regulated markets such as the US and Europe.
07-Aug-25 12-Sep-25 12-Sep-25 3 Rs.3.0000 per share(150%)Final Dividend 15-May-25 30-May-25 30-May-25 3 Rs.3.0000 per share(150%)Interim Dividend 15-May-25 30-May-25 30-May-25 3 Rs.3.0000 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results